Get in touch today 206.598.4100 or

Schedule an Appointment

Ethan Balkin, PhD

Assistant Professor

Education and Training

College:  University of Missouri, Columbia, MO, 2004

Graduate School: University of Missouri, Columbia, MO, 2011

Fellowship: Postdoctoral Fellowship, Department of Radiation Oncology, University of Washington, Seattle, WA, 2014

Published Works

Bryan, J.N., Kumar, S.R., Jia, F., Balkin, E.R., and Lewis, M.R. Zebularine Significantly Sensitizes CLL cells to External Irradiation and Radiopharmaceutical Therapy When Administered Sequentially. Cell Biol. Int., 2014; 38(2): 187-197.

Balkin, E.R., Jia, F., Ruthengael, V.C., Shaffer, S.M., Miller, W.H., Lewis, M.R. Comparative biodistributions and dosimetry of [177Lu]DOTA-anti-bcl-2-PNA-Tyr3-octreotate and [177Lu]DOTA-Tyr3- octreotate in a mouse model of B-cell lymphoma/leukemia. Nucl. Med. Biol., 2014; 41: 36-42.

Balkin, E.R., Hamlin, D.K., Gagnon, K., Chyan, M.K., Pal, S., Watanabe, S., Wilbur, D.S. Evaluation of a Wet Chemistry Method for Isolation of Cyclotron Produced [211At]Astatine. Appl. Sci., 2013; 3: 636-655

Orozco, J.J., Bäck, T.A., Kenoyer, A., Balkin, E.R., Anti-CD45 Radioimmunotherapy Using 211At with Bone Marrow Transplantation Prolongs Survival in a Disseminated Murine Leukemia Model. Blood, 2013; 121(18): 3759-67.